Science and Technology Science and Technology
Wed, January 15, 2025
[ 09:42 PM ] - deseret
Trump's Energy nominee says he wants to 'restore our energy dominance'
[ 09:42 PM ] - cnycentral
Senator Schumer announces $825M final agreement for Albany Nanotech
[ 09:22 PM ] - MSN
Micron's rapid gains in HBM and DRAM rattle South Korean rivals
[ 09:22 PM ] - MSN
Deccan eruptions: How lava sparked a tropical floral revival
[ 09:02 PM ] - MSN
Scientists successfully demonstrated long-lasting quantum entanglement between molecules
[ 08:02 PM ] - MSN
2 privately built moon landers carried into space by SpaceX rocket
[ 06:42 PM ] - MSN
New technology gives us a look into the future of .. s and transportation: 'No longer science fiction'
[ 06:22 PM ] - MSN
Do The Benefits of AI Justify The Costs? Here Are 6 Questions You Need to Ask Before You Commit
[ 06:22 PM ] - MSN
UW initiative 'Society + Technology' aims to foster broad collaboration at critical intersection
[ 05:22 PM ] - MSN
AbbVie and Simcere Zaiming link to develop trispecific antibody
[ 05:02 PM ] - MSN
2 private lunar landers head toward the moon in a roundabout journey
[ 05:02 PM ] - MSN
AI predicts properties of molten salts for modeli .. safer and more sustainable nuclear power reactors
[ 04:42 PM ] - deseret
Energy nominee Chris Wright fields questions in Senate hearing
[ 04:22 PM ] - MSN
Ultrasound-directed microbubbles could boost immune response against tumors
[ 02:22 PM ] - MSN
Researchers make troubling discovery while studyi .. 'A critical aspect ... that is often overlooked'
[ 02:22 PM ] - MSN
Schumer: Deal done for $825M Albany NanoTech chip lab
[ 01:22 PM ] - NDTV
US Removes Restrictions On 3 Indian Nuclear Entities
[ 12:42 PM ] - Indiatimes
US removes India's BARC, IRE, IGCAR from 'entity list' to enable closer cooperation
[ 12:22 PM ] - MSN
4 ways to correct bad data and improve your AI
[ 12:22 PM ] - katv
Little Rock Central High teacher wins national award for excellence in STEM education
[ 12:02 PM ] - MSN
'Magic-wavelength optical tweezers' achieve quantum entanglement of molecules
[ 11:42 AM ] - MSN
HP Board 12th Computer Science Model Paper 2025: Download Class 12 Sample Paper PDF For FREE!
[ 11:22 AM ] - techUK
Tech Policy: A Year in Review 2024
[ 11:22 AM ] - Forbes
Work-Based Learning For Emerging Technologies And Advanced Industries
[ 10:42 AM ] - MSN
'A nationally distinctive model of community science design'
[ 10:22 AM ] - MSN
Nuclear energy research drives innovation in Gen-IV reactor safety and efficiency
[ 10:22 AM ] - MSN
Stochastic Taylor Derivative Estimator: Unlocking the power of high-dimensional simulations
[ 10:22 AM ] - KIMT
Osage teacher gets Presidential Excellence award
[ 10:02 AM ] - Forbes
10 Careers Predicted To Get Big Pay Raises In 2025
[ 10:02 AM ] - AOL
US imposing new export controls on biotech equipment over China concerns

AbbVie and Simcere Zaiming link to develop trispecific antibody


Published on 2025-01-15 17:22:26 - MSN
  Print publication without navigation

  • The humanised trispecific antibody is undergoing Phase I trials in the US and China in subjects with relapsed or refractory MM.

AbbVie, a leading biopharmaceutical company, has entered into a collaboration with Simcere Zaiming, a Chinese biotech firm, to develop a trispecific antibody aimed at treating cancer. This partnership leverages Simcere Zaiming's expertise in trispecific T cell-engaging antibodies, which are designed to simultaneously target three different antigens, potentially enhancing the effectiveness of cancer immunotherapy. The agreement includes AbbVie making an upfront payment to Simcere Zaiming, with further milestone payments and royalties on future sales if the product successfully reaches the market. This collaboration not only signifies AbbVie's commitment to expanding its oncology portfolio but also highlights the growing trend of international partnerships in the biotech industry to accelerate drug development.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/science/biology/abbvie-and-simcere-zaiming-link-to-develop-trispecific-antibody/ar-AA1xgBc4 ]
Contributing Sources